Indian vaccine proves 'highly efficacious'

By Agence France-Presse

Nov 13, 2021 12:27 am

PARIS, France: Covaxin, the first Covid-19 vaccine developed in India, is 'highly efficacious' and presents no safety concerns, according to a study published in the Lancet on Thursday.

Covaxin, developed by Bharat Biotech, gained emergency approval from the World Health Organization (WHO) last week and has already been cleared for use in 17 countries.

A health worker inoculates a woman with a dose of the Covaxin vaccine against Covid-19 at a health center in New Delhi on Oct. 21, 2021. India administered its billionth Covid-19 vaccine dose on October 21, according to the health ministry, half a year after a devastating surge in cases brought the health system close to collapse. AFP photo

Already have an active account? Log in here to continue reading.
Or
Subscribe to the Premium Subscription plan to access this subscriber-exclusive article.

Related Articles

The benefits of a four-day workweek according to a champion of the trend

Alcohol-free beer is gaining popularity, even at Oktoberfest

Meryl Streep says a 'squirrel has more rights' than an Afghan girl

Belgian child abuse scandals to dominate papal visit

World leaders meet under shadow of global divisions, 3 wars and possible Mideast conflict

New Zealand scientists discover ghostly 'spookfish'

Leftist leader sworn in as Sri Lanka's president